Wall Street falls as trade hopes wane
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
Apple (AAPL) Opens Lower as Tech Pressured, Down 2.75%
December 3, 2019 9:31 AM ESTApple (NASDAQ: AAPL) Opens Lower as Tech Pressured, Down 2.75%
... MoreH.C. Wainwright Downgrades Audentes Therapeutics (BOLD) to Neutral Following Acquisition
December 3, 2019 7:15 AM ESTH.C. Wainwright analyst Debjit Chattopadhyay downgraded Audentes Therapeutics (NASDAQ: BOLD) from Buy to Neutral.
For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.
Shares of Audentes Therapeutics closed at $28.61 yesterday.
... MoreMizuho Securities Downgrades Audentes Therapeutics (BOLD) to Neutral Following Acquisition
December 3, 2019 6:53 AM ESTMizuho Securities analyst Difei Yang downgraded Audentes Therapeutics (NASDAQ: BOLD) from Buy to Neutral with a price target of $60.00.
For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.
Shares of Audentes Therapeutics closed at $28.61 yesterday.
... More